11 results
endocrinology summary inhibitors medications agonists dosing dpp4 glp1 management sglt2 table adverse antipsychotics atypical decisionaid inpatient mellitus metformin overview profiles
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. #pharmacology
mechanism of action, side ... commonly used diabetic ... #pharmacology #dm2 ... #diabetes #medications ... overview #management #comparison
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... disease Common Side ... #Metformin #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Sulfonylureas - Pharmacology Summary Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... in CKD Common Side ... Sulfonylureas #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... of use) Common Side ... • Euglycemic diabetic ... #Summary #DM2 # ... diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... insulin in Type 1 Diabetes ... #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... drugs include side ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Toxicities: • Gl side ... Receptor #Agonists #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... failure Common Side ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... Common side effects ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
Side Effects of Atypical and Typical Antipsychotics - Comparison Table Atypical antipsychotics: Risperidone, Quetiapine, Olanzapine, Amisulpride, Ziprasidone
Side Effects of ... Antipsychotics - Comparison ... development of diabetes ... Adverse #Profiles #Comparison ... Table #Psychiatry #Pharmacology
No results found for "Wide pocus pharmacology pulmonaryembolism diabetes comparison dm2"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Wide #pocus #pharmacology #pulmonaryembolism #diabetes #comparison #dm2